<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03559491</url>
  </required_header>
  <id_info>
    <org_study_id>2018oculistica</org_study_id>
    <nct_id>NCT03559491</nct_id>
  </id_info>
  <brief_title>Dexamethasone Intravitreal Implant in Retinal Vein Occlusion</brief_title>
  <official_title>Evaluation of the Effectiveness of Treatment With Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To evaluate retinal functional improvement by means of visual acuity and retinal
      sensibility examination after intravitreal dexamethasone implant in patients affected by
      cystoid macular edema secondary to retinal vein occlusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cystoid macular edema represents the most important cause of visual impairment after retinal
      vein occlusion. The etiological factors of this complication are under investigation, from
      inflammatory cytokines to the breakdown of vascular barrier with increased permeability and
      diffusion of angiogenic factors. Clinical research developed different drugs and therapeutic
      strategies to treat and control macular edema, to evaluate the correct timetable and to reach
      long-term clinical significative results. At now, different experiences have been published
      with available drugs, from steroids to anti Vascular Endothelial Growth Factor. A debate
      still remains about the correct approach, the correct combination of drugs (if necessary) and
      the correct evaluation of drug effectiveness.

      In our study, we will evaluate extensive functional recovery and its relation to macular
      thickness after steroid injection. Considering that visual acuity reflects only foveal
      function, it may not be sufficient to evaluate the overall function on the macular area. We
      introduce microperimetry study as a valuable and reproducible tool to create a functional
      mapping of the entire macula.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>6 months</time_frame>
    <description>evaluation of visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>retinal sensibility</measure>
    <time_frame>6 months</time_frame>
    <description>microperimetry evaluation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Macular Edema, Cystoid</condition>
  <arm_group>
    <arm_group_label>Macular Edema Patients</arm_group_label>
    <description>Patients affected by cystoid macular edema (CME) due to retinal vein occlusion of recent onset (less than three months) will be enrolled.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravitreal injection</intervention_name>
    <description>Long term release steroid injection</description>
    <arm_group_label>Macular Edema Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected by cystoid macular edema (CME) due to retinal vein occlusion of recent
        onset (less than three months) were enrolled
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria were: age older than 18 years; CME secondary to retinal vein occlusion,
        disease duration inferior to 12 weeks; best-corrected visual acuity (BCVA) between 20/200
        and 20/25 (Snellen equivalent) in the study eye at baseline examination, central retinal
        thickness (CRT) superior to 300 mm, as measured by optical coherence tomography at baseline
        examination.

        The exclusion criteria were any ocular surgery in the study eye in the past 6 months;
        diabetes mellitus with signs of diabetic retinopathy; previous laser photocoagulation;
        previous intravitreal injection of corticosteroids or anti-vascular endothelial growth
        factor; a history of ocular inflammation; marked retinal ischemia or retinal hemorrhages
        (in particular in macular region involving the fovea); any other ocular condition such as
        anterior ischemic neuropathy, amblyopia or significant media opacities; significant
        alteration on epiretinal surface such as epiretinal membrane or vitreomacular traction;
        uncontrolled or advanced glaucoma; any uncontrolled systemic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simone Donati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università dell'Insubria</affiliation>
  </overall_official>
  <reference>
    <citation>Querques G, Lattanzio R, Querques L, Triolo G, Cascavilla ML, Cavallero E, Del Turco C, Casalino G, Bandello F. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Retina. 2014 Feb;34(2):330-41. doi: 10.1097/IAE.0b013e31829f7495.</citation>
    <PMID>23945638</PMID>
  </reference>
  <results_reference>
    <citation>Garweg JG, Zandi S. Impact of treatment on long-term visual function in retinal vein occlusion-response to the comment on: retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2479-2480. Epub 2016 Sep 7.</citation>
    <PMID>27604764</PMID>
  </results_reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 5, 2018</last_update_submitted>
  <last_update_submitted_qc>June 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Simone Donati</investigator_full_name>
    <investigator_title>Study Investigator</investigator_title>
  </responsible_party>
  <keyword>steroid</keyword>
  <keyword>retinal vein occlusion</keyword>
  <keyword>macular edema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Retinal Vein Occlusion</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

